Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 May;17(5):374-7.

[Role of IL-6/STAT3 in rat cholangiocyte proliferation induced by lipopolysaccharide]

[Article in Chinese]
Affiliations
  • PMID: 19497205

[Role of IL-6/STAT3 in rat cholangiocyte proliferation induced by lipopolysaccharide]

[Article in Chinese]
Li-ping CHEN et al. Zhonghua Gan Zang Bing Za Zhi. 2009 May.

Abstract

Objective: To investigate whether lipopolysaccharide (LPS) stimulates cholangiocyte proliferation via the IL-6/STAT3 pathway in vivo.

Methods: Rats were randomized into three groups: LPS group (injected intravenously with LPS 2.5 mg/kg), anti-IL-6 group (injected intravenously with anti-IL-6 0.5 mg/kg 1hr after LPS injection), and control group. At 6, 12, 24, 48 and 72 h after LPS injection, LPS concentration in plasma was detected by kinetic turbidimetric limulus test. IL-6 concentrations in liver homogenate was determinded by ELISA, cholangiocyte proliferation was checked by immunohistochemistry, expression of IL-6 mRNA was quantified by real-time RT-PCR, the level of phophorylated-STAT3 (P-STAT3) protein was analyzed by western blotting.

Results: Cholangiocytes responded to LPS by a marked increase in cell proliferation, IL-6 secretion and P-STAT3 expression. Anti-IL-6 neutralizing antibody inhibited LPS-induced cholangiocytes proliferation, and decreased levels of IL-6 and p-STAT3.

Conclusions: LPS promotes cholangiocyte proliferation through the IL-6/STAT3 pathway.

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources